ClinicalTrials.Veeva

Menu

Noninvasive Transcutaneous Vagal Nerve Stimulation (tcVNS) for Neuromodulating the Conscious State

Northwestern University logo

Northwestern University

Status

Withdrawn

Conditions

Cognitive Function
Delirium
Depression
Anesthesia

Treatments

Device: Vagus nerve stimulator
Device: Placebo comparator sham

Study type

Interventional

Funder types

Other

Identifiers

NCT07191340
STU00217188

Details and patient eligibility

About

The purpose of this study is to examine whether noninvasive, transcutaneous vagal nerve stimulation (tcVNS) (Gammacore Sapphire Device) can help restore consciousness in patients in the Operating Room and Post Anesthesia Care Unit (PACU). To examine whether tcVNS administered in the PACU can help reduce delirium and depression post-surgery, speeding up cognitive recovery from anesthesia, and finally determine if tcVNS can expedite discharge from the PACU.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged > 18 years of age
  • Patients undergoing lumbar surgery for degenerative disc disease or spinal stenosis involving two or more levels
  • Mini-Mental State Examination (MMSE) score ≥ 15-accept mild
  • Ability to use a keyboard
  • Able to understand and communicate in English
  • Be able to consent independently
  • Women of child-bearing age must be comfortable confirming a negative pregnancy prior to participating in the study.
  • Must not be involved in any other research intervention study testing neurobehavioral functioning
  • Good internet connectivity and ability to use computer, smart phone or good telephone connectivity (follow up)

Exclusion criteria

  • Age < 18 years of age
  • History of vagotomy (cutting the vagus nerve)
  • History of bradycardia, heart block, prolonged QT syndrome, brugada syndrome, heart failure with ejection fraction less than 35% and/or New York Heart Association symptoms
  • MMSE < 15
  • History of seizure disorder or intracranial hemorrhage
  • Patients with carotid stenosis
  • Patients with aneurysms
  • Other neurological diagnoses or a diagnosis of severe psychiatric disorder (e.g., psychosis) or a reported childhood learning disability
  • Pregnancy, breastfeeding
  • Active addiction history
  • ECG adhesive allergy
  • Severe aphasia, preventing subject from understanding the protocol and giving written consent
  • Patients with an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device
  • Patients with metallic device such as a stent, bone plate or bone screw implanted at or near their neck
  • Patients with an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device
  • Patients with metallic device such as a stent, bone plate or bone screw implanted at or near their neck
  • Patients who are using another device at the same time (e.g., transcutaneous electrical nerve stimulation (TENS) Unit, muscle stimulator) or any portable electronic device (e.g., mobile phone).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

0 participants in 2 patient groups, including a placebo group

Treatment Group Stimulation of Vagus Nerve
Active Comparator group
Description:
Stimulation of the vagus nerve with nerve stimulator placed on neck
Treatment:
Device: Vagus nerve stimulator
Sham Placebo Group No Stimulation to Vagus Nerve
Placebo Comparator group
Description:
Nerve stimulator placed on neck but not activated.
Treatment:
Device: Placebo comparator sham

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems